Note: trial status changes over time
Tirzepatide Telehealth Alabama: Eligibility and Contraindications Alabama providers prescribing tirzepatide through telehealth follow clinical eligibility criteria aligned with the SURMOUNT trial inclusion parameters: BMI 30 kg/m or BMI 27 kg/m with at least one weight-related comorbidity (hypertension, dyslipidemia, obstructive sleep apnea, prediabetes)
This peptide has specific structural modifications, including an amino acid change and the addition of a fatty acid side chain
In the present study, utilising the above-described novel, highly translatable two-session operant food intake paradigm, rhesus macaques were administered GLP-1R agonist Ex to elucidate how GLP-1R agonism differentially modulates homoeostatic feeding regulation, hedonic valuation and palatability-driven anticipation and decision making across the two daily feeding sessions
Caution: If you are pregnant or nursing, consult your physician before taking this product
Chemical strategies for half-life extension of biopharmaceuticals: Lipidation and its alternatives